Harvest Fund Management Co., LTD Incyte Corp Transaction History

Harvest Fund Management Co., LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$51.18 - $63.75 $125,032 - $155,741	2,443 New	2,443 $148,000
Q4 2023 Feb 01, 2024	BUY	$52.16 - $64.19 $18,621 - $22,915	357 New	357 $22,000
Q4 2021 Feb 11, 2022	SELL	$63.34 - $74.11 $14,884 - $17,415	-235 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$76.02 - $100.5 $17,864 - $23,617	235 New	235 $19,000
Q4 2020 Feb 10, 2021	SELL	$80.74 - $97.7 $1,372 - $1,660	-17 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$85.07 - $109.69 $30,795 - $39,707	-362 Reduced 95.51%	17 $1,000
Q2 2020 Aug 12, 2020	BUY	$74.18 - $108.93 $28,114 - $41,284	379 New	379 $38,000
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $178,117 - $211,627	-2,446 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $71,534 - $86,305	973 Added 66.06%	2,446 $208,000
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $93,623 - $129,874	1,473 New	1,473 $127,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Harvest Fund Management Co., LTD, based on Form 13F filings with the SEC.

Stay updated on Harvest Fund Management Co., LTD with notifications on news.